The FDA sends Warning Letters and 483s to companies that significantly violate FDA regulations. We gather those related to computer system issues so that you can help ensure your organization doesn’t fail an inspection for similar violations.

Organizations who received warning letters citing computer system issues:

F.P. Rubinstein Y Cia

This Warning Letter contains many observations impacting software quality, including failures in validation, software safety, and qualification of software consultants and contractors. Download this warning letter.

Interpharm Praha

This Warning Letter contains multiple observations regarding the integrity of laboratory system data, including the deletion of at least 1,441 test results.

Tosoh Bioscience

This Warning Letter cites the failure to investigate the installation of the wrong version of software in a medical product. Download this warning letter.

Teva Pharmaceutical Works

This Warning Letter contains citations for failure to prevent deletion of laboratory system records and failure to review system audit trails. Download this warning letter.

Our consultants have extensive pharmaceutical, biotech, and medical device industry experience. If you are facing an FDA inspection, EMA inspection, or customer audit, it’s not too late to get help.

Talk to our CSV experts today about how they can help you meet FDA and international regulatory expectations.

To download other FDA Warning Letters and 483s, visit our document Library.

Like it? Share it:

You may also like

AI & CGMP: FDA's 1st Warning Letter on Non-Compliant AI in Manufacturing
23 April, 2026

The FDA’s April 2026 Warning Letter to Purolea Cosmetics Lab is a notable milestone for the pharmaceutical industry. Whi...

Are you ready for the FDA guidance on the design of Interoperable Medical Devices?
11 February, 2016

If your electronic medical device exchanges data with other devices, you need to read the new draft guidance just publis...

Are you complying with the new FDA General Wellness Policy for Low Risk Devices?
19 August, 2016

In July 2016, the FDA released Guidance for Industry and FDA Staff – General Wellness: Policy for Low-Risk Devices to cl...